Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Researching, developing and commercializing therapies for the treatment of patients with elevated332.31M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Collaboration revenue216.59M65.18%
United States115.73M34.82%